← Eichor
Study identifier: NCT06788912 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

Condition: Lung Neoplasm Malignant  ·  Sponsor: Merck Sharp & Dohme LLC

PhasePhase 2
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main goals are after treatment given before surgery, to measure the number of people who have no signs of cancer cells in tumors and lymph nodes removed during surgery; and to learn about whether the cancer gets smaller or goes away by measuring the number of people with a certain number of living cancer cells in the tumor removed during surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Toll Free Number  ·  1-888-577-8839  ·  Trialsites@msd.com

Always discuss trial participation with your own doctor first.

Locations (38)

Southern Cancer Center (SCC) ( Site 8004)Daphne, Alabama, United StatesRecruiting
Sansum Clinic (Ridley Tree) ( Site 8012)Santa Barbara, California, United StatesRecruiting
Rocky Mountain Cancer Centers (RMCC) ( Site 8011)Lone Tree, Colorado, United StatesRecruiting
MedStar Franklin Square Medical Center ( Site 0033)Baltimore, Maryland, United StatesRecruiting
Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8006)Eugene, Oregon, United StatesRecruiting
Texas Oncology - Central/South Texas ( Site 8009)Austin, Texas, United StatesRecruiting
Texas Oncology - Northeast Texas ( Site 8005)Tyler, Texas, United StatesRecruiting
Virginia Cancer Specialists (VCS) ( Site 8002)Fairfax, Virginia, United StatesRecruiting
Centro de Estudios Clínicos SAGA ( Site 0162)Santiago, Region M. de Santiago, ChileRecruiting
FALP ( Site 0161)Santiago, Region M. de Santiago, ChileRecruiting
Bradfordhill ( Site 0160)Santiago, Region M. de Santiago, ChileRecruiting
Alexandra General Hospital of Athens Oncology-Hematology Unit ( Site 0203)Athens, Attica, GreeceRecruiting

+ 26 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06788912